JP Morgan sets $36.50 price target for Pacira BioSciences
JP Morgan raised its rating on Pacira BioSciences to Neutral from Underweight and set a $36.50 per-share price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.